LY210073 is a Leukotriene B4 (LTB4) receptor antagonist with an IC50 of 6.2 nM.
LY210073 is a Leukotriene B4 (LTB4) receptor antagonist with an IC50 of 6.2±0.1 nM. LY2100731 (Compound 32) appears to be one of the strongest inhibitors of LTB4 receptor binding reported so far[1].
[1]. Jackson WT, et al. Design, synthesis, and pharmacological evaluation of potent xanthone dicarboxylic acid leukotriene B4 receptor antagonists. J Med Chem. 1993 Jun 11;36(12):1726-34.
















